Literature DB >> 8199532

An association between osteoporosis and premenstrual symptoms and postmenopausal symptoms.

S J Lee1, J A Kanis.   

Abstract

This study examined the relationship of premenstrual and postmenopausal symptoms with vertebral osteoporosis by means of a retrospective case control questionnaire in patients with vertebral osteoporosis and control patients. Seventy-five postmenopausal women aged 55-70 years with vertebral osteoporosis and 77 age-matched controls were interviewed at the outpatient clinics of the Royal Hallamshire Hospital, Sheffield, UK to establish the past history of premenstrual symptoms, and present and past history of postmenopausal vasomotor symptoms. The risk of vertebral osteoporosis was significantly greater in women with a history of premenstrual symptoms (RR = 1.86) or oligomenorrhoea (RR = 3.08). Significantly more patients with osteoporosis than controls recalled vasomotor symptoms at the time of the menopause (RR = 1.35). Patients were more likely than controls to describe their symptoms as severe (RR = 1.43) or persistent (RR = 2.19). We conclude that the relative risk of vertebral osteoporosis is increased in women with a history of premenstrual symptoms, irregular periods, and with severe and/or persistent menopausal vasomotor symptoms.

Entities:  

Mesh:

Year:  1994        PMID: 8199532     DOI: 10.1016/s0169-6009(08)80150-x

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  8 in total

1.  Associations of menopausal vasomotor symptoms with fracture incidence.

Authors:  Carolyn J Crandall; Aaron Aragaki; Jane A Cauley; JoAnn E Manson; Erin LeBlanc; Robert Wallace; Jean Wactawski-Wende; Andrea LaCroix; Mary Jo O'Sullivan; Mara Vitolins; Nelson B Watts
Journal:  J Clin Endocrinol Metab       Date:  2014-12-18       Impact factor: 5.958

2.  Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density.

Authors:  Lubna Pal; John Norian; Gohar Zeitlian; Kris Bevilacqua; Ruth Freeman; Nanette Santoro
Journal:  Fertil Steril       Date:  2008-02-20       Impact factor: 7.329

3.  Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis.

Authors:  Carolyn J Crandall; Yan Zheng; Sybil L Crawford; Rebecca C Thurston; Ellen B Gold; Janet M Johnston; Gail A Greendale
Journal:  Menopause       Date:  2009 Mar-Apr       Impact factor: 2.953

Review 4.  Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Authors:  S Rozenberg; N Al-Daghri; M Aubertin-Leheudre; M-L Brandi; A Cano; P Collins; C Cooper; A R Genazzani; T Hillard; J A Kanis; J-M Kaufman; I Lambrinoudaki; A Laslop; E McCloskey; S Palacios; D Prieto-Alhambra; J-Y Reginster; R Rizzoli; G Rosano; F Trémollieres; N C Harvey
Journal:  Osteoporos Int       Date:  2020-07-08       Impact factor: 4.507

5.  Menstrual abnormalities post-COVID vaccination: a cross-sectional study on adult Lebanese women.

Authors:  Ahmad Ayman Dabbousi; Jad El Masri; Lemir Majed El Ayoubi; Omar Ismail; Bachir Zreika; Pascale Salameh
Journal:  Ir J Med Sci       Date:  2022-07-26       Impact factor: 2.089

6.  Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome: A randomized, double-blind, controlled trial.

Authors:  Hajar Dadkhah; Elham Ebrahimi; Nahid Fathizadeh
Journal:  Iran J Nurs Midwifery Res       Date:  2016 Mar-Apr

7.  Women's Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  Evelyn M M Wong; George Tomlinson; Marsha M Pinto; Claudie Berger; Angela M Cheung; Jerilynn C Prior
Journal:  Int J Environ Res Public Health       Date:  2018-05-26       Impact factor: 3.390

8.  Efficacy and Safety of Kudzu Flower-Mandarin Peel on Hot Flashes and Bone Markers in Women during the Menopausal Transition: A Randomized Controlled Trial.

Authors:  Ji Eon Kim; Hyeyun Jeong; Soohee Hur; Junho Lee; Oran Kwon
Journal:  Nutrients       Date:  2020-10-22       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.